search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


A safety and growth study with a new fat blend.


- candidate number13503
- NTR NumberNTR3683
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR2-nov-2012
- Secondary IDsEPI.1.C/A Danone Research
- Public TitleA safety and growth study with a new fat blend.
- Scientific TitleA randomised, controlled, double-blind trial to investigate the effects of a new infant formula on growth, tolerance and safety in healthy term infants.
- ACRONYMMercurius
- hypothesisBased on the human milk composition, Danone Research has developed a new infant formula with a new fat blend, more similar to that of human milk. This new formula is currently being studied for safety and its effects on growth.
The comparator used in the study is a standard infant formula containing the standard fat blend.
- Healt Condition(s) or Problem(s) studiedHealthy children, Early feeding
- Inclusion criteria1. Healthy term (gestational age >= 37 1/7 and <= 42 6/7 weeks);
2. Age <= 35 days (preferably as soon as possible after birth);
3. Birth weight within normal range (10th to 90th percentile);
4. Exclusively formula fed (mothers who have chosen not to breastfeed or mothers who ended breastfeeding by time of inclusion), or;
5. Exclusively breastfed (mothers willing to exclusively breastfeed at least till 13 weeks of age (and preferably till 17 weeks of age);
6. Written informed consent from parent(s) and/or legal guardian, aged ≥ 18 years.
- Exclusion criteria1. Known current or previous illnesses/conditions or intervention which could interfere with the study or its outcome parameters;
2. Mother known to suffer from hepatitis B or human immunodeficiency virus (HIV);
3. Need to be fed with a special diet other than standard (non hydrolysed) cowˇ®s milk-based infant formula;
4. Currently participating or have participated in any other study involving investigational or marketed products;
5. Incapability of the parent(s) to comply with study protocol or investigator's uncertainty about the willingness or ability of the parent(s) to comply with the protocol requirements.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingDouble
- control[default]
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 16-sep-2012
- planned closingdate30-nov-2013
- Target number of participants276
- InterventionsDuration of intervention: 13-17 weeks.
Intervention group: Standard infant formula containing the new fat blend.
Control group: Standard infant formula containing the standard fat blend.
Reference group: Human milk.
- Primary outcomeTo investigate equivalence of weight gain from randomisation until the age of 17 weeks.
- Secondary outcome1. To investigate equivalence of other growth parameters;
2. To assess gastrointestinal tolerance and safety.
- Timepoints1. V2 (Week 4);
2. V3 (Week 8);
3. V4 (week 13);
4. V5 (Week 17).
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESDr. L. Stet
- CONTACT for SCIENTIFIC QUERIESDr. L. Stet
- Sponsor/Initiator Nutricia Research – Centre for Specialised Nutrition
- Funding
(Source(s) of Monetary or Material Support)
Nutricia Research - Centre for Specialised Nutrition
- PublicationsN/A
- Brief summaryIn this study standard infant formula containing a new fat blend is compared with standard infant formula containing the standard fat blend. The main parameter being studied is growth. Furthermore, gastrointestinal tolerance and safety are studied. The results are also compared to a breastfeeding reference group. In total 88 healthy term infants will be included per study arm. The infants will be included in the study until they are 35 days of age, study product intake will be until they are 4 months of age. There will be a follow-up period of two weeks.
The infants need to visit the investigative site maximally 5 times. Parents will be asked to fill in a diary with information on some of the parameters, and one questionnaire. Furthermore, they will be asked to collect a stool sample 1 to 2 times during the study. There is one voluntary blood draw, at 3 months of age. In between visits there will be a phone call from the site staff.
The study is planned to start Q3 2012, and planned to be completed Q4 2013.
- Main changes (audit trail)
- RECORD2-nov-2012 - 4-jan-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl